Role of interleukin-6 in the pathogenesis of murine plasmacytoma and human multiple myeloma.

P K Pattengale

Abstract readComment

In one paragraph

Article in The American journal of pathology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it

0cells of the map it votes in

7citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

Syndrome of inappropriate antidiuresis secondary to multiple myeloma: a case report and literature review.Frontiers in oncology · 2026
Article
Tumor-associated macrophages in multiple myeloma: advances in biology and therapy.Journal for immunotherapy of cancer · 2022
Review
Interleukin-6 at the Host-Tumor Interface: STAT3 in Biomolecular Condensates in Cancer Cells.Cells · 2022
Review
Reactive plasmacytosis mimicking multiple myeloma associated with SFTS virus infection: a report of two cases and literature review.BMC infectious diseases · 2018
Review
Massive plasmacytosis with severe marrow suppression induced by methimazole in Graves' disease patients: case report and literature review.International journal of clinical and experimental medicine · 2014
Article
Characterization of a novel mouse model of multiple myeloma and its use in preclinical therapeutic assessment.PloS one · 2013
Article
Assessing the potential carcinogenic activity of magnetic fields using animal models.Environmental health perspectives · 2000
Review

4 · The record

Corrections and comments

Comment on
Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.1997

5 · Who and what money

Authors and funding

1 author.

P K PattengaleDepartment of Pathology, Children's Hospital, Los Angeles, California 90027, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell Transformation, NeoplasticAnimalsB-LymphocytesDisease Models, AnimalHumansImmunoglobulinsInterleukin-6MiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMultiple MyelomaPlasmacytomaProto-Oncogene Proteins c-mycTerpenesImmunoglobulinsInterleukin-6pristaneProto-Oncogene Proteins c-mycTerpenes

Identifiers

PMID9284811

PMCPMC1857849

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.